The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Mean platelet volume: a potential biomarker of the risk and prognosis of heart disease

  • Choi, Dong-Hyun (Department of Internal Medicine, Chosun University School of Medicine) ;
  • Kang, Seong-Ho (Department of Laboratory Medicine, Chosun University School of Medicine) ;
  • Song, Heesang (Department of Biochemistry and Molecular Biology, Chosun University School of Medicine)
  • Received : 2016.02.22
  • Accepted : 2016.10.04
  • Published : 2016.11.01
⟨ Previous Next ⟩

Abstract

Platelets are essential for progression of atherosclerotic lesions, plaque destabilization, and thrombosis. They secrete and express many substances that are crucial mediators of coagulation, inflammation, and atherosclerosis. Mean platelet volume (MPV) is a precise measure of platelet size, and is routinely reported during complete blood count analysis. Emerging evidence supports the use of MPV as a biomarker predicting the risk of ischemic stroke in patients with atrial fibrillation, and as a guide for prescription of anticoagulation and rhythm-control therapy. In addition, MPV may predict the clinical outcome of percutaneous coronary intervention (PCI) in patients with coronary artery disease and indicate whether additional adjunctive therapy is needed to improve clinical outcomes. This review focuses on the current evidence that MPV may be a biomarker of the risk and prognosis of common heart diseases, particularly atrial fibrillation and coronary artery disease treated via PCI.

Keywords

Acknowledgement

Supported by : National Research Foundation of Korea (NRF)

References

  1. Coppinger JA, Cagney G, Toomey S, et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 2004;103:2096-2104. https://doi.org/10.1182/blood-2003-08-2804
  2. Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005;115:3378-3384. https://doi.org/10.1172/JCI27196
  3. Karpatkin S. Heterogeneity of human platelets. II. Functional evidence suggestive of young and old platelets. J Clin Invest 1969;48:1083-1087. https://doi.org/10.1172/JCI106064
  4. Kamath S, Blann AD, Lip GY. Platelet activation: assessment and quantification. Eur Heart J 2001;22:1561-1571. https://doi.org/10.1053/euhj.2000.2515
  5. Bath PM, Butterworth RJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996;7:157-161. https://doi.org/10.1097/00001721-199603000-00011
  6. Tsiara S, Elisaf M, Jagroop IA, Mikhailidis DP. Platelets as predictors of vascular risk: is there a practical index of platelet activity? Clin Appl Thromb Hemost 2003;9:177-190. https://doi.org/10.1177/107602960300900301
  7. Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des 2011;17:47-58. https://doi.org/10.2174/138161211795049804
  8. Chugh SS, Roth GA, Gillum RF, Mensah GA. Global burden of atrial fibrillation in developed and developing nations. Glob Heart 2014;9:113-119. https://doi.org/10.1016/j.gheart.2014.01.004
  9. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-2375. https://doi.org/10.1001/jama.285.18.2370
  10. Greisenegger S, Endler G, Hsieh K, Tentschert S, Mannhalter C, Lalouschek W. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke 2004;35:1688-1691. https://doi.org/10.1161/01.STR.0000130512.81212.a2
  11. Ha SI, Choi DH, Ki YJ, et al. Stroke prediction using mean platelet volume in patients with atrial fibrillation. Platelets 2011;22:408-414. https://doi.org/10.3109/09537104.2011.560306
  12. Bayar N, Arslan S, Cagirci G, et al. Usefulness of mean platelet volume for predicting stroke risk in paroxysmal atrial fibrillation patients. Blood Coagul Fibrinolysis 2015;26:669-672. https://doi.org/10.1097/MBC.0000000000000334
  13. Turfan M, Erdogan E, Ertas G, et al. Usefulness of mean platelet volume for predicting stroke risk in atrial fibrillation patients. Blood Coagul Fibrinolysis 2013;24:55-58. https://doi.org/10.1097/MBC.0b013e32835a0850
  14. Hong SP, Choi DH, Kim HW, et al. Stroke prevention in patients with non-valvular atrial fibrillation: new insight in selection of rhythm or rate control therapy and impact of mean platelet volume. Curr Pharm Des 2013;19:5824-5829. https://doi.org/10.2174/13816128113199990075
  15. Xu XF, Jiang FL, Ou MJ, Zhang ZH. The association between mean platelet volume and chronic atrial fibrillation and the presence of thrombotic events. Biomed Rep 2015;3:388-394. https://doi.org/10.3892/br.2015.418
  16. Providencia R, Faustino A, Paiva L, et al. Mean platelet volume is associated with the presence of left atrial stasis in patients with non-valvular atrial fibrillation. BMC Cardiovasc Disord 2013;13:40. https://doi.org/10.1186/1471-2261-13-40
  17. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007;146:857-867. https://doi.org/10.7326/0003-4819-146-12-200706190-00007
  18. Gillis AM, Verma A, Talajic M, Nattel S, Dorian P; CCS Atrial Fibrillation Guidelines Committee. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management. Can J Cardiol 2011;27:47-59. https://doi.org/10.1016/j.cjca.2010.11.001
  19. Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-1833. https://doi.org/10.1056/NEJMoa021328
  20. Van Gelder IC, Hagens VE, Bosker HA, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002;347:1834-1840. https://doi.org/10.1056/NEJMoa021375
  21. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation. Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet 2000;356:1789-1794. https://doi.org/10.1016/S0140-6736(00)03230-X
  22. Carlsson J, Miketic S, Windeler J, et al. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol 2003;41:1690-1696. https://doi.org/10.1016/S0735-1097(03)00332-2
  23. Opolski G, Torbicki A, Kosior DA, et al. Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study. Chest 2004;126:476-486. https://doi.org/10.1378/chest.126.2.476
  24. Tsadok MA, Jackevicius CA, Essebag V, et al. Rhythm versus rate control therapy and subsequent stroke or transient ischemic attack in patients with atrial fibrillation. Circulation 2012;126:2680-2687. https://doi.org/10.1161/CIRCULATIONAHA.112.092494
  25. Sherman DG, Kim SG, Boop BS, et al. Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study. Arch Intern Med 2005;165:1185-1191. https://doi.org/10.1001/archinte.165.10.1185
  26. Huczek Z, Kochman J, Filipiak KJ, et al. Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol 2005;46:284-290. https://doi.org/10.1016/j.jacc.2005.03.065
  27. Maden O, Kacmaz F, Selcuk H, et al. Relationship of admission hematological indexes with myocardial reperfusion abnormalities in acute ST segment elevation myocardial infarction patients treated with primary percutaneous coronary interventions. Can J Cardiol 2009;25:e164-e168. https://doi.org/10.1016/S0828-282X(09)70090-X
  28. Pereg D, Berlin T, Mosseri M. Mean platelet volume on admission correlates with impaired response to thrombolysis in patients with ST-elevation myocardial infarction. Platelets 2010;21:117-121. https://doi.org/10.3109/09537100903487599
  29. Acar Z, Aga MT, Kiris A, et al. Mean platelet volume on admission is associated with further left ventricular functions in primary PTCA patients. Eur Rev Med Pharmacol Sci 2012;16:1567-1569.
  30. Akgul O, Uyarel H, Pusuroglu H, et al. Prognostic value of elevated mean platelet volume in patients undergoing primary angioplasty for ST-elevation myocardial infarction. Acta Cardiol 2013;68:307-314. https://doi.org/10.1080/AC.68.3.2983426
  31. Rechcinski T, Jasinska A, Forys J, et al. Prognostic value of platelet indices after acute myocardial infarction treated with primary percutaneous coronary intervention. Cardiol J 2013;20:491-498. https://doi.org/10.5603/CJ.2013.0134
  32. Celik T, Kaya MG, Akpek M, et al. Predictive value of admission platelet volume indices for in-hospital major adverse cardiovascular events in acute ST-segment elevation myocardial infarction. Angiology 2015;66:155-162. https://doi.org/10.1177/0003319713513493
  33. Elbasan Z, Gur M, Sahin DY, et al. Association of mean platelet volume and pre- and postinterventional flow with infarct-related artery in ST-segment elevation myocardial infarction. Angiology 2013;64:440-446. https://doi.org/10.1177/0003319712455685
  34. Sarli B, Baktir AO, Saglam H, et al. Mean platelet volume is associated with poor postinterventional myocardial blush grade in patients with ST-segment elevation myocardial infarction. Coron Artery Dis 2013;24:285-289. https://doi.org/10.1097/MCA.0b013e328360eff6
  35. Karahan Z, Ucaman B, Ulug AV, et al. Effect of hematologic parameters on microvascular reperfusion in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Angiology 2016;67:151-156. https://doi.org/10.1177/0003319715583204
  36. Lai HM, Chen QJ, Yang YN, et al. Association of mean platelet volume with impaired myocardial reperfusion and short-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Blood Coagul Fibrinolysis 2016;27:5-12. https://doi.org/10.1097/MBC.0000000000000388
  37. Lai HM, Xu R, Yang YN, et al. Association of mean platelet volume with angiographic thrombus burden and short-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Catheter Cardiovasc Interv 2015;85 Suppl 1:724-733. https://doi.org/10.1002/ccd.25860
  38. Cakici M, Cetin M, Balli M, et al. Predictors of thrombus burden and no-reflow of infarct-related artery in patients with ST-segment elevation myocardial infarction: importance of platelet indices. Blood Coagul Fibrinolysis 2014;25:709-715. https://doi.org/10.1097/MBC.0000000000000130
  39. Wang XY, Yu HY, Zhang YY, et al. Serial changes of mean platelet volume in relation to Killip Class in patients with acute myocardial infarction and primary percutaneous coronary intervention. Thromb Res 2015;135:652-658. https://doi.org/10.1016/j.thromres.2015.01.033
  40. Duygu H, Turkoglu C, Kirilmaz B, Turk U. Effect of mean platelet volume on postintervention coronary blood flow in patients with chronic stable angina pectoris. J Invasive Cardiol 2008;20:120-124.
  41. Goncalves SC, Labinaz M, Le May M, et al. Usefulness of mean platelet volume as a biomarker for long-term outcomes after percutaneous coronary intervention. Am J Cardiol 2011;107:204-209. https://doi.org/10.1016/j.amjcard.2010.08.068
  42. Eisen A, Bental T, Assali A, Kornowski R, Lev EI. Mean platelet volume as a predictor for long-term outcome after percutaneous coronary intervention. J Thromb Thrombolysis 2013;36:469-474. https://doi.org/10.1007/s11239-013-0876-1
  43. Ki YJ, Park S, Ha SI, Choi DH, Song H. Usefulness of mean platelet volume as a biomarker for long-term clinical outcomes after percutaneous coronary intervention in Korean cohort: a comparable and additive predictive value to high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide. Platelets 2014;25:427-432. https://doi.org/10.3109/09537104.2013.835393
  44. Seo HJ, Ki YJ, Han MA, Choi DH, Ryu SW. Brachial-ankle pulse wave velocity and mean platelet volume as predictive values after percutaneous coronary intervention for long-term clinical outcomes in Korea: a comparable and additive study. Platelets 2015;26:665-671. https://doi.org/10.3109/09537104.2014.978274
  45. Moon AR, Choi DH, Jahng SY, et al. High-sensitivity C-reactive protein and mean platelet volume as predictive values after percutaneous coronary intervention for long-term clinical outcomes: a comparable and additive study. Blood Coagul Fibrinolysis 2016;27:70-76. https://doi.org/10.1097/MBC.0000000000000398
  46. Seyyed-Mohammadzad MH, Eskandari R, Rezaei Y, et al. Prognostic value of mean platelet volume in patients undergoing elective percutaneous coronary intervention. Anatol J Cardiol 2015;15:25-30. https://doi.org/10.5152/akd.2014.5169
  47. Choi SW, Choi DH, Kim HW, Ku YH, Ha SI, Park G. Clinical outcome prediction from mean platelet volume in patients undergoing percutaneous coronary intervention in Korean cohort: implications of more simple and useful test than platelet function testing. Platelets 2014;25:322-327. https://doi.org/10.3109/09537104.2013.821606
  48. Kim YG, Suh JW, Yoon CH, et al. Platelet volume indices are associated with high residual platelet reactivity after antiplatelet therapy in patients undergoing percutaneous coronary intervention. J Atheroscler Thromb 2014;21:445-453. https://doi.org/10.5551/jat.20156
  49. Koh YY, Kim HH, Choi DH, et al. Relation between the change in mean platelet volume and clopidogrel resistance in patients undergoing percutaneous coronary intervention. Curr Vasc Pharmacol 2015;13:687-693. https://doi.org/10.2174/1570161112666141017121118
  50. Cameron HA, Phillips R, Ibbotson RM, Carson PH. Platelet size in myocardial infarction. Br Med J (Clin Res Ed) 1983;287:449-451. https://doi.org/10.1136/bmj.287.6390.449
  51. Kilicli-Camur N, Demirtunc R, Konuralp C, Eskiser A, Basaran Y. Could mean platelet volume be a predictive marker for acute myocardial infarction? Med Sci Monit 2005;11:CR387-CR392.
  52. Martin JF, Plumb J, Kilbey RS, Kishk YT. Changes in volume and density of platelets in myocardial infarction. Br Med J (Clin Res Ed) 1983;287:456-459. https://doi.org/10.1136/bmj.287.6390.456
  53. Tschoepe D, Roesen P, Kaufmann L, et al. Evidence for abnormal platelet glycoprotein expression in diabetes mellitus. Eur J Clin Invest 1990;20:166-170. https://doi.org/10.1111/j.1365-2362.1990.tb02264.x
  54. Giles H, Smith RE, Martin JF. Platelet glycoprotein IIb-IIIa and size are increased in acute myocardial infarction. Eur J Clin Invest 1994;24:69-72. https://doi.org/10.1111/j.1365-2362.1994.tb02062.x
  55. Pabon Osuna P, Nieto Ballesteros F, Morinigo Munoz JL, et al. The effect of the mean platelet volume on the short-term prognosis of acute myocardial infarct. Rev Esp Cardiol 1998;51:816-822. https://doi.org/10.1016/S0300-8932(98)74825-0
  56. Lekston A, Hudzik B, Hawranek M, et al. Prognostic significance of mean platelet volume in diabetic patients with ST-elevation myocardial infarction. J Diabetes Complications 2014;28:652-657. https://doi.org/10.1016/j.jdiacomp.2014.05.002
  57. Sezer M, Okcular I, Goren T, et al. Association of haematological indices with the degree of microvascular injury in patients with acute anterior wall myocardial infarction treated with primary percutaneous coronary intervention. Heart 2007;93:313-318. https://doi.org/10.1136/hrt.2006.094763
  58. Chu SG, Becker RC, Berger PB, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 2010;8:148-156. https://doi.org/10.1111/j.1538-7836.2009.03584.x
  59. Shah B, Oberweis B, Tummala L, et al. Mean platelet volume and long-term mortality in patients undergoing percutaneous coronary intervention. Am J Cardiol 2013;111:185-189. https://doi.org/10.1016/j.amjcard.2012.09.014
  60. Braekkan SK, Mathiesen EB, Njolstad I, Wilsgaard T, Stormer J, Hansen JB. Mean platelet volume is a risk factor for venous thromboembolism: the Tromso Study, Tromso, Norway. J Thromb Haemost 2010;8:157-162. https://doi.org/10.1111/j.1538-7836.2009.03498.x
  61. Kostrubiec M, Labyk A, Pedowska-Wloszek J, et al. Mean platelet volume predicts early death in acute pulmonary embolism. Heart 2010;96:460-465. https://doi.org/10.1136/hrt.2009.180489
  62. Shanker J, Gasparyan AY, Kitas GD, Kakkar VV. Platelet function and antiplatelet therapy in cardiovascular disease: implications of genetic polymorphisms. Curr Vasc Pharmacol 2011;9:479-489. https://doi.org/10.2174/157016111796197224
  63. Gasparyan AY, Watson T, Lip GY. The role of aspirin in cardiovascular prevention: implications of aspirin resistance. J Am Coll Cardiol 2008;51:1829-1843. https://doi.org/10.1016/j.jacc.2007.11.080
  64. Snoep JD, Hovens MM, Eikenboom JC, van der Bom JG, Jukema JW, Huisman MV. Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis. Am Heart J 2007;154:221-231. https://doi.org/10.1016/j.ahj.2007.04.014
  65. Patti G, Nusca A, Mangiacapra F, Gatto L, D'Ambrosio A, Di Sciascio G. Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study. J Am Coll Cardiol 2008;52:1128-1133. https://doi.org/10.1016/j.jacc.2008.06.038
  66. Price MJ, Endemann S, Gollapudi RR, et al. Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. Eur Heart J 2008;29:992-1000. https://doi.org/10.1093/eurheartj/ehn046
  67. Bonello L, Pansieri M, Mancini J, et al. High on-treatment platelet reactivity after prasugrel loading dose and cardiovascular events after percutaneous coronary intervention in acute coronary syndromes. J Am Coll Cardiol 2011;58:467-473. https://doi.org/10.1016/j.jacc.2011.04.017
  68. Paulu P, Osmancik P, Tousek P, et al. Lack of association between clopidogrel responsiveness tested using point-of-care assay and prognosis of patients with coronary artery disease. J Thromb Thrombolysis 2013;36:1-6. https://doi.org/10.1007/s11239-012-0813-8
  69. Collet JP, Cuisset T, Range G, et al. Bedside monitoring to adjust antiplatelet therapy for coronary stenting. N Engl J Med 2012;367:2100-2109. https://doi.org/10.1056/NEJMoa1209979
  70. Michelson AD. Methods for the measurement of platelet function. Am J Cardiol 2009;103(3 Suppl):20A-26A. https://doi.org/10.1016/j.amjcard.2008.11.019
  71. Leader A, Pereg D, Lishner M. Are platelet volume indices of clinical use? A multidisciplinary review. Ann Med 2012;44:805-816. https://doi.org/10.3109/07853890.2011.653391
  72. Brummitt DR, Barker HF. The determination of a reference range for new platelet parameters produced by the Bayer ADVIA120 full blood count analyser. Clin Lab Haematol 2000;22:103-107. https://doi.org/10.1046/j.1365-2257.2000.00285.x
  73. Song YH, Park SH, Kim JE, et al. Evaluation of platelet indices for differential diagnosis of thrombocytosis by ADVIA 120. Korean J Lab Med 2009;29:505-509. https://doi.org/10.3343/kjlm.2009.29.6.505

Cited by

  1. Stroke or left atrial thrombus prediction using antithrombin III and mean platelet volume in patients with nonvalvular atrial fibrillation vol.40, pp.11, 2016, https://doi.org/10.1002/clc.22759
  2. Baseline platelet parameters for predicting early platelet response and clinical outcomes in patients with non-cardioembolic ischemic stroke treated with clopidogrel vol.8, pp.55, 2016, https://doi.org/10.18632/oncotarget.21622
  3. Effects of Platelet Number and Platelet Indices on Platelet Reactivity in Patients Treated with Clopidogrel or Ticagrelor vol.92, pp.6, 2016, https://doi.org/10.3904/kjm.2017.92.6.526
  4. Mean platelet volume is associated with serum 25-hydroxyvitamin D concentrations in patients with stable coronary artery disease vol.33, pp.11, 2016, https://doi.org/10.1007/s00380-018-1182-9
  5. The Link Between Mean Platelet Volume to Lymphocyte Ratio and Complexity of Coronary Artery Disease vol.69, pp.4, 2016, https://doi.org/10.1177/0003319717743315
  6. The Link Between Mean Platelet Volume to Lymphocyte Ratio and Complexity of Coronary Artery Disease vol.69, pp.4, 2016, https://doi.org/10.1177/0003319717743315
  7. A study of association between platelet volume indices and ST elevation myocardial infarction vol.21, pp.None, 2016, https://doi.org/10.1016/j.ijcha.2018.09.001
  8. Correlation of Paraoxonase-1 with the Severity of Crohn’s Disease vol.23, pp.10, 2016, https://doi.org/10.3390/molecules23102603
  9. Combination of Mean Platelet Volume and Neutrophil to Lymphocyte Ratio Predicts Long-Term Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention vol.70, pp.4, 2019, https://doi.org/10.1177/0003319718768658
  10. Platelet Indices as the Predictor of Antibiotics Response in Surgical Wound Infections Following Total Abdominal Hysterectomy vol.53, pp.2, 2016, https://doi.org/10.14744/semb.2019.46693
  11. Blood Cell Parameters and Predicting Coronary In-Stent Restenosis vol.70, pp.8, 2019, https://doi.org/10.1177/0003319719830495
  12. Analysis of Post-Sample Collection EDTA Effects on Mean Platelet Volume Values in Relation to Overweight and Obese Patient Status vol.142, pp.3, 2016, https://doi.org/10.1159/000499101
  13. Psoriasis and Psoriatic Arthritis Cardiovascular Disease Endotypes Identified by Red Blood Cell Distribution Width and Mean Platelet Volume vol.9, pp.1, 2016, https://doi.org/10.3390/jcm9010186
  14. Comparative study between complete blood picture indices and presepsin as early prognostic markers in septic shock patients vol.36, pp.1, 2020, https://doi.org/10.1080/11101849.2020.1789403
  15. Mean platelet volume: a new predictor of ischaemic stroke risk in patients with nonvalvular atrial fibrillation vol.20, pp.None, 2016, https://doi.org/10.1186/s12872-020-01525-x
  16. The relationship between mean platelet volume and reverse dipping blood pressure pattern in patients with essential hypertension vol.43, pp.7, 2021, https://doi.org/10.1080/10641963.2021.1937203
  17. Blood biomarkers of progressive atherosclerosis and restenosis after stenting of symptomatic intracranial artery stenosis vol.11, pp.1, 2016, https://doi.org/10.1038/s41598-021-95135-y